Get the Stockscreener App
91.65
1.79%
-1.67
After Hours:
95.53
3.88
+4.23%
Zimmer Biomet Holdings Inc stock is traded at $91.65, with a volume of 1.80M.
It is down -1.79% in the last 24 hours and up +0.48% over the past month.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
See More
Previous Close:
$93.32
Open:
$92.06
24h Volume:
1.80M
Relative Volume:
0.83
Market Cap:
$18.13B
Revenue:
$7.68B
Net Income/Loss:
$903.80M
P/E Ratio:
20.60
EPS:
4.45
Net Cash Flow:
$1.14B
1W Performance:
-5.39%
1M Performance:
+0.48%
6M Performance:
-16.29%
1Y Performance:
-17.69%
1-Day Range:
$91.56
$93.20
1-Week Range:
$91.56
$97.76
52-Week Range:
$89.24
$116.71
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Name
Zimmer Biomet Holdings Inc
Sector
Industry
Phone
(574) 267-6131
Address
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
91.65 | 18.46B | 7.68B | 903.80M | 1.14B | 4.45 |
|
ABT
Abbott Laboratories
|
126.19 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.92 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
392.73 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
90.24 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.31 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-15-25 | Upgrade | Roth Capital | Neutral → Buy |
| Dec-17-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Peer Perform |
| Jul-01-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-30-24 | Initiated | Goldman | Neutral |
| May-21-24 | Upgrade | Argus | Hold → Buy |
| Jan-04-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-23 | Initiated | ROTH MKM | Neutral |
| Aug-28-23 | Upgrade | BTIG Research | Neutral → Buy |
| May-03-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Apr-11-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-31-23 | Upgrade | Jefferies | Underperform → Hold |
| Mar-29-23 | Initiated | UBS | Sell |
| Mar-10-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-05-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Underweight |
| Oct-12-22 | Initiated | Jefferies | Underperform |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Apr-01-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Underperform |
| Mar-02-22 | Downgrade | Loop Capital | Buy → Hold |
| Feb-08-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Feb-08-22 | Reiterated | Citigroup | Buy |
| Feb-08-22 | Reiterated | Deutsche Bank | Hold |
| Feb-08-22 | Reiterated | JMP Securities | Mkt Outperform |
| Feb-08-22 | Reiterated | JP Morgan | Neutral |
| Feb-08-22 | Reiterated | RBC Capital Mkts | Sector Perform |
| Feb-08-22 | Reiterated | Stifel | Buy |
| Feb-08-22 | Reiterated | Truist | Buy |
| Feb-08-22 | Reiterated | UBS | Neutral |
| Feb-08-22 | Reiterated | Wells Fargo | Underweight |
| Feb-02-22 | Downgrade | UBS | Buy → Neutral |
| Jan-19-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-10-22 | Downgrade | Mizuho | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-09-21 | Downgrade | Needham | Strong Buy → Buy |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Nov-23-21 | Downgrade | Argus | Buy → Hold |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-09-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jan-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-18-20 | Reiterated | Needham | Strong Buy |
| Oct-20-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Aug-05-20 | Reiterated | Needham | Strong Buy |
| Apr-28-20 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-09-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Apr-07-20 | Reiterated | Needham | Strong Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jan-07-20 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-19 | Upgrade | Raymond James | Outperform → Strong Buy |
| Oct-07-19 | Upgrade | BTIG Research | Neutral → Buy |
| Sep-18-19 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-12-19 | Upgrade | Argus | Hold → Buy |
| Jul-30-19 | Upgrade | Barclays | Underweight → Equal Weight |
| Jul-29-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jun-11-19 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Apr-24-19 | Upgrade | Needham | Buy → Strong Buy |
View All
Zimmer Biomet Holdings Inc Stock (ZBH) Latest News
Needham Maintains a Neutral Stance on Zimmer Biomet Holdings (ZBH) - MSN
Analysts Estimate Zimmer Biomet (ZBH) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Monogram Orthopaedics Updates on Zimmer Biomet Acquisition - TipRanks
MGRM files 8-K on shareholder text amid Zimmer Biomet deal - Stock Titan
Leading vs lagging indicators on Zimmer Biomet Holdings Inc. performanceWatchlist for Smart Swing Trading Updated - metal.it
Can Zimmer Biomet Holdings Inc. Rally Enough to Break EvenConfirmed Setup With Expert Accuracy Supported - metal.it
Wyckoff Accumulation Phase Possible in Zimmer Biomet Holdings Inc.Breakout Momentum Picks With Protection Outlined - beatles.ru
Why Zimmer Biomet Holdings Inc. stock attracts strong analyst attentionTrend Analysis for Safer Trades Gains Popularity - metal.it
Published on: 2025-07-29 10:18:45 - metal.it
Zimmer Biomet Holdings Inc. Approaches Psychological Resistance LevelWeekly Top Gainers Forecast Watchlist Released - metal.it
Monogram Orthopaedics Announces Acquisition by Zimmer Biomet - TipRanks
How Zimmer Biomet Holdings Inc. stock reacts to Fed policy changesEntry Points For Growing Stocks Identified by Models - metal.it
Does Zimmer Biomet Holdings Inc. stock perform well during market downturnsFree Consultation - jammulinksnews.com
When is Zimmer Biomet Holdings Inc. stock expected to show significant growthLow Risk Picks With Proven Results - jammulinksnews.com
What are Zimmer Biomet Holdings Inc. company’s key revenue driversFinancial News Target Finder That Work - jammulinksnews.com
What institutional investors are buying Zimmer Biomet Holdings Inc. stockPost Market Guidance With High Returns - jammulinksnews.com
Should I hold or sell Zimmer Biomet Holdings Inc. stock in 2025Turbocharged investment results - jammulinksnews.com
How volatile is Zimmer Biomet Holdings Inc. stock compared to the marketIdentify undervalued stocks poised to rally - jammulinksnews.com
What are the latest earnings results for Zimmer Biomet Holdings Inc.Maximize your portfolio’s earning power - jammulinksnews.com
What is the risk reward ratio of investing in Zimmer Biomet Holdings Inc. stockHigh-yield trading alerts - jammulinksnews.com
How does Zimmer Biomet Holdings Inc. compare to its industry peersFree Stock Selection - jammulinksnews.com
What analysts say about Zimmer Biomet Holdings Inc. stockFree Stock Movement Tracking - PrintWeekIndia
Is Zimmer Biomet Holdings Inc. a good long term investmentOutstanding capital appreciation - PrintWeekIndia
Spine Surgery Devices Market Is Booming So Rapidly 2025-2032Zimmer Biomet Holdings Inc., Stryker Corporation - openPR.com
Collagen Meniscus Implant Market Set to Witness Significant - openPR.com
Zimmer Biomet Holdings Inc. Stock Analysis and ForecastExplosive returns - Autocar Professional
Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions - ADVFN Brasil
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2025 Financial Results - Yahoo.co
P/E Ratio Insights for Zimmer Biomet Holdings - 富途牛牛
Zimmer Biomet to Acquire Monogram Technologies for $168M - AInvest
What drives Zimmer Biomet Holdings Inc. stock priceDynamic profit expansion - jammulinksnews.com
Zimmer Biomet Q2 Preview: Combining Monogram Autonomous Robotics With ROSA (NYSE:ZBH) - Seeking Alpha
Jim Cramer Expresses Bullishness on Zimmer’s Acquisition of Monogram Technologies - MSN
Zimmer Biomet (ZBH): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
What You Need To Know Ahead of Zimmer Biomet's Earnings Release - MSN
Zimmer Biomet Holdings Inc Stock (ZBH) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):